MYH11 and invasive carcinoma: While pathologic analysis did not find an overt invasive component, the lack of highlighting of myoepithelial cells within fibrovascular cores, by immunostaining for p63, SMMHC, and CK5/6, was not re-assuring (Figure 3), which is the main objective criterion to distinguish in situ from invasive carcinoma [7].